Dr. Jason Bush, Chief Scientific Officer, and Jason Leibert, Chief Growth Officer at Solnul®, join the podcast to discuss the science, clinical research, upcycling, and commercialization behind Solnul® resistant potato starch.
The conversation covers what makes resistant starch different, why clinical trials matter, how Solnul® supports the gut microbiome at a low daily dose, and how the ingredient is being used across supplements and functional food applications.
In this episode
- Resistant starch and the microbiome
- Clinical research and ingredient credibility
- Upcycling potato co-products
- Product development and commercialization
- Building adoption through science and collaboration
Meta title: Solnul® Podcast: Resistant Starch, Science and Commercialization
Meta description: Dr. Jason Bush and Jason Leibert discuss Solnul® resistant potato starch, microbiome science, clinical research, upcycling, and ingredient commercialization.
